Digest Network Come funziona
Network
/
Società
Ka
Non verificato

Kardigan

Di cosa scriviamo

BiotecnologiaCardiologiaFarmaceuticaIndustriaSalute

9 comunicati stampa

Guarda tutti i comunicati
28/03/2026
Eventi
Industria
Scienza
Cardiologia
Biotecnologia
Farmaceutica
Salute
Igiene alimentare
Medicina - Varie
Kardigan Announces Positive Phase 2 Data for Tonlamarsen in Patients with Uncontrolled Hypertension Presented as Late-Breaker at ACC.26 and Simultaneously Published in JACC
Fonte
Kardigan
Emittente
Business Wire
1.00
0
17/03/2026
Attrezzature medico-sanitarie
Igiene alimentare
Medicina - Varie
Cardiologia
Biotecnologia
Salute
Farmaceutica
Sanità
Fiere
Eventi
Kardigan Announces Multiple Presentations at ACC.26 from its Late-Stage Portfolio of Personalized Cardiovascular Medicines
Fonte
Kardigan
Emittente
Business Wire
1.00
0
06/01/2026
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Cardiologia
Mercato del lavoro
Eventi
Industria
Kardigan Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference and Provides Corporate Update for 2026
Fonte
Kardigan
Emittente
Business Wire
1.00
0
07/11/2025
Farmaceutica
Salute
Medicina - Varie
Cardiologia
Industria
Kardigan Presents Positive Phase 2 Data on Ataciguat in Patients With Moderate Calcific Aortic Valve Stenosis at American Heart Association Scientific Sessions 2025
Fonte
Kardigan
Emittente
Business Wire
1.00
0
14/10/2025
Biotecnologia
Farmaceutica
Salute
Cardiologia
Industria
Kardigan Raises $254 Million Series B to Advance Late-Stage Portfolio of Personalized Cardiovascular Medicines
Fonte
Kardigan
Emittente
Business Wire
1.00
0
29/09/2025
Eventi
Industria
Salute
Medicina - Varie
Farmaceutica
Cardiologia
Biotecnologia
Kardigan Announces Presentation of Positive Phase 2a Data for Danicamtiv in Patients with Dilated Cardiomyopathy at HFSA Annual Scientific Meeting 2025
Fonte
Kardigan
Emittente
Business Wire
1.00
0
25/09/2025
Industria
Salute
Medicina - Varie
Farmaceutica
Cardiologia
Biotecnologia
Kardigan Advances Late-Stage Portfolio of Personalized Cardiovascular Medicines in Dilated Cardiomyopathy, Acute Severe Hypertension and Calcific Aortic Valve Stenosis
Fonte
Kardigan
Emittente
Business Wire
1.00
0
27/03/2025
Multimedialità
Mercato azionario
Salute
Tecnica
Software
Farmaceutica
Cardiologia
Biotecnologia
Kardigan Acquires Prolaio to Create a Pioneering Heart Health Company with One-of-a-Kind Integrated Cardiovascular Data and Therapeutics Platform
Fonte
Kardigan
Emittente
Business Wire
1.00
0
10/01/2025
Mercato del lavoro
Scienza
Cardiologia
Biotecnologia
Farmaceutica
Salute
Associazioni/Professionisti
Kardigan Launches with Industry-Leading Team to Modernize Cardiovascular Drug Development with Late-Stage Portfolio of Personalized Medicines
Fonte
Kardigan
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0